Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Adobe stock slides on BMO downgrade: “no clear catalyst” and competition in focus

Adobe stock slides on BMO downgrade: “no clear catalyst” and competition in focus

New York, January 9, 2026, 20:54 EST — Market closed Adobe shares ended down 1.5% at $333.95 on Friday, after trading between $328.00 and $340.44, following a downgrade by BMO Capital Markets. The broker cut the Photoshop maker to Market Perform from Outperform and lowered its price target to $375 from $400, saying its latest Creative Cloud survey showed competition rising among students, freelancers and smaller businesses. “We do not envision a clear catalyst for the stock,” BMO analyst Keith Bachman wrote, flagging risks to pricing power and high-end seat growth. (Investing.com) The call lands at an awkward moment for
D.R. Horton (DHI) stock jumps nearly 8% on Trump mortgage-bond order — what to watch next

D.R. Horton (DHI) stock jumps nearly 8% on Trump mortgage-bond order — what to watch next

New York, January 9, 2026, 20:43 ET — Market closed. D.R. Horton’s stock surged 7.8% on Friday, closing at $157.28, following President Donald Trump’s directive to buy $200 billion in mortgage bonds to help lower housing costs. (MarketWatch) The shift is crucial since homebuilders are directly linked to mortgage rates: even a slight change in monthly payments can shift demand. Lower rates also reduce the need for builders to throw in incentives to close sales. Trump’s order focuses on mortgage-backed securities, those bundles of home loans sold to investors. FHFA director Bill Pulte confirmed Fannie Mae and Freddie Mac will
Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

New York, Jan 9, 2026, 20:13 EST — Market closed Lululemon Athletica shares dropped 3.9% on Friday, ending the day at $203.90 after dipping to an intraday low of $200.56. The stock pulled back sharply from a high of $213.50, settling close to a key round number watched by short-term traders. The market slide followed a recalibration around tariff risks after the U.S. Supreme Court hinted its next batch of rulings might drop on Jan. 14. Among them is a pending challenge to President Donald Trump’s wide-ranging tariffs. The case questions whether Trump can rely on a 1977 emergency-powers statute
Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

New York, Jan 9, 2026, 20:08 EST — Market closed. Cisco Systems shares slipped slightly on Friday after the U.S. Supreme Court agreed to hear the company’s appeal in a lawsuit claiming it aided China in targeting Falun Gong practitioners. The stock closed down about 0.1% at $73.88. A Cisco spokesperson said the company welcomed the court’s decision and looked forward to oral arguments. (Reuters) The legal headline hits as U.S. stocks kick off 2026 on a strong note, valuations already running high with limited space for surprises. The S&P 500 closed at a record high on Friday, shrugging off
Mastercard stock slips on ex-dividend day as Apple Card network win, CPI loom

Mastercard stock slips on ex-dividend day as Apple Card network win, CPI loom

NEW YORK, Jan 9, 2026, 20:10 EST — Market closed Mastercard (MA) shares fell 0.8% on Friday to $575.54, after trading between $575.00 and $581.26. The move came on a day Wall Street pushed higher, with the S&P 500 closing at a record after a softer December jobs report. The backdrop matters for payment networks because rate bets and growth fears can quickly spill into spending expectations. (Reuters) Away from the tape, Apple said JPMorgan Chase will become the new issuer of Apple Card, while Mastercard stays on as the payments network. “We’re thrilled to work with Apple and Chase
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

New York, Jan 9, 2026, 20:01 (EST) — Market closed. Merck & Co (MRK.N) shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines (RVMD.O) for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46. (Reuters) The possible bid comes as Merck looks to bolster its oncology portfolio ahead of patent cliffs on its blockbuster Keytruda later this decade. Such a deal would arrive amid investor pressure on big pharma to weigh pipeline investments against buybacks and dividends, especially with interest
Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

NEW YORK, January 9, 2026, 20:00 EST — Market closed. Shares of The Goldman Sachs Group Inc (GS) closed Friday up roughly 0.4%, finishing at $938.98, gaining $4.15 from Thursday’s close. The stock fluctuated between $932.84 and $946.14 during the session, with around 1.1 million shares changing hands. Goldman now faces a hectic period as major U.S. banks prepare to kick off fourth-quarter earnings. Investors will be watching closely for early signals on the economy and deal activity. “The banks are going to be telling you something that is going to be pretty important because they’re on the front lines,”
Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

New York, Jan 9, 2026, 20:26 EST — Market closed Shares of Credo Technology Group Holding Ltd (CRDO) climbed 6.2% to $150.42 on Friday. Needham stuck with a buy rating, set a $220 price target, and added the AI connectivity supplier to its conviction list. The stock fluctuated between $141.34 and $157.47, valuing the company at roughly $32.5 billion. (Investing.com) Money is pouring into the infrastructure supporting artificial-intelligence data centers, not just the big-name chipmakers. For smaller suppliers, one positive analyst call can spark a rapid influx of cash — and just as quickly, selling follows when the headlines shift.
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

New York, January 9, 2026, 19:58 EST — After-hours BitMine Immersion Technologies, Inc. (BMNR) shares fell 3.9% to close at $30.06 on Friday following the appointment of Young Kim as CFO and COO. Trading volume hit around 37.6 million shares. The timing is crucial. BitMine’s annual shareholder meeting is just days away, and on the agenda is a proposal to raise its authorized share count — the limit in its charter on how many shares it can issue. The vote has kept the stock on edge, as investors debate how much leeway the company aims for in equity compensation and
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

New York, Jan 9, 2026, 19:58 (ET) — After-hours NuScale Power Corp shares climbed late Friday following a Bank of America upgrade. The small modular reactor developer—known for its factory-built nuclear units—was raised to neutral with a $28 price target, MarketBeat said. The stock was last up 4.3% at $20.51, after reaching $22.49 earlier in the day, per market data. (MarketBeat) Timing is key. Wall Street has been factoring in a sharp rise in U.S. power demand driven by AI and data centers, bringing nuclear energy back into focus. On Friday, Meta Platforms inked 20-year deals to purchase power from
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

New York, January 9, 2026, 20:18 (EST) — Market closed AbbVie Inc. shares dropped 1.8% on Friday, closing at $220.08. The decline followed the drugmaker’s decision to lower its 2025 earnings forecast and a denial of reports suggesting it was in talks to acquire cancer-drug developer Revolution Medicines. Since 2023, AbbVie has spent over $20 billion on acquisitions, aiming to offset the impact from Humira’s patent expiration. (Reuters) The updated forecast is crucial since AbbVie’s deals aim to replace lost growth, and this charge came late in the year when investors were already preparing for a rough transition from aging
CrowdStrike stock bounces as $740 million SGNL deal and fresh upgrade shift focus to identity security

CrowdStrike stock bounces as $740 million SGNL deal and fresh upgrade shift focus to identity security

New York, Jan 9, 2026, 20:15 EST — Market closed CrowdStrike Holdings Inc shares gained 1.4%, closing at $470.61 on Friday, recovering some losses after the company announced a $740 million acquisition of identity security startup SGNL and received an analyst upgrade. The timing is crucial because “identity”—the log-ins and permissions controlling access to company data—has grown into a major vulnerability as firms link more cloud apps and test software “agents” operating with minimal human oversight. Security buyers are also looking to cut down on vendor numbers, a move that generally favors broad platforms over standalone products. (Nasdaq) CrowdStrike announced

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop